ADCT-402
ADCT-402-102
Phase 1 small_molecule terminated
Quick answer
ADCT-402 for Acute Lymphoblastic Leukemia is a Phase 1 program (small_molecule) at ADC Therapeutics SA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ADC Therapeutics SA
- Indication
- Acute Lymphoblastic Leukemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated